Mohammad Jahanzeb

Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

Hope S. Rugo, R. Bryan Rumble, Erin Macrae et al. · Journal of Clinical Oncology · 2016 · 645 citations · Full text

Medicine, Endocrinology, Oncology +15

A Process for Measuring the Quality of Cancer Care: The Quality Oncology Practice Initiative

Michael N. Neuss, Christopher E. Desch, Kristen K. McNiff et al. · Journal of Clinical Oncology · 2005 · 246 citations

Medicine, Oncology, Cancer Pain Management +13

HER2 Testing in Breast Cancer: NCCN Task Force Report and Recommendations

Robert W. Carlson, Susan J. Moench, M. Elizabeth H. Hammond et al. · Journal of the National Comprehensive Cancer Network · 2006 · 208 citations · Full text

Medicine, Oncology, Pathology +17

Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial

James Chih‐Hsin Yang, D. Ross Camidge, Cheng‐Ta Yang et al. · Journal of Thoracic Oncology · 2020 · 156 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12

Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs

Sara A. Hurvitz, Joyce O’Shaughnessy, Ginny Mason et al. · Clinical Cancer Research · 2018 · 114 citations

Medicine, Oncology, Breast Oncology +16